“RenalytixAI Receives Approval From New York State to Offer Kidney Test”
Kidney disease diagnostics firm RenalytixAI announced Friday it has received a clinical laboratory permit from the New York State Department of Health allowing the company to provide its KidneyIntelX test to residents of the state. The London-based artificial intelligence company said it will now move to complete KidneyIntelX's full commercial launch with Mount Sinai Health System and will likely start reporting patient results in the third quarter of 2020.
Press Release
FDA Grants Breakthrough Device Designation to KidneyIntelX™
May 02, 2019 View All Press Releases